Sleepless in America: A pathway to obesity and the metabolic syndrome?

Archives of Internal Medicine

Volumn 165, Issue 1, 2005, Pages 15-16

  Bass, Joseph ^a   Turek, Fred W ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; OREXIN;

ARTHRITIS; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; BODY MASS; CANCER; CARBOHYDRATE INTAKE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; EDITORIAL; HOMEOSTASIS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; LIFESTYLE; LOW FAT DIET; METABOLIC SYNDROME X; METABOLISM; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SIGNAL TRANSDUCTION; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP PATTERN; SLEEP TIME; SLEEP WAKING CYCLE; STROKE; UNITED STATES;

HUMANS; METABOLIC SYNDROME X; OBESITY; SLEEP INITIATION AND MAINTENANCE DISORDERS; UNITED STATES;

EID: 11844259365     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.165.1.15     Document Type: Editorial

References (13)

1. Ford ES. Prevalence of the metabolic syndrome in US populations. Endocrinol Metab Clin North Am. 2004;33:333-350.
2. Gluckman PD, Hanson MA. The developmental origins of the metabolic syndrome. Trends Endocrinol Metab. 2004;15:183-187.
3. Vorona R, Winn MP, Babineau TW, Eng BP, Feldman HR, Ware JC. Overweight and obese patients in a primary care population report less sleep than patients with a normal body mass index. Arch Intern Med. 2005;165:25-30.
4. Reaven G. Syndrome X. In: DeGroot LJ, Jameson JL, eds. Endocrinology. 4th ed. Philadelphia, Pa: WB Saunders Co; 2001:954-958.
5. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354:1435-1439.
6. Van Cauter E, Copinschi G, Turek FW. Endocrine and other biologic rhythms. In: DeGroot LJ, Jameson JL, eds. Endocrinology. 4th ed. Philadelphia, Pa: WB Saunders Co; 2001:235-256.
7. Ferreira I, Twisk JWR, van Mechelen W, Kemper HCG, Stehouwer CDA. Development of fatness, fitness, and lifestyle from adolescence to the age of 36 years: determinants of the metabolic syndrome in young adults: the Amsterdam Growth and Health Longitudinal Study. Arch Intern Med. 2005;165:42-48.
8. National Sleep Foundation. The 2004 NSF National Sleep in America Poll. Available at: www.sleepfoundation.org. Accessed October 7, 2004.
9. Kiess W, Marcus C, Wabitsch M, eds. Obesity in Childhood and Adolescence. Leipzig, Germany: Karger; 2004. Pediatric and Adolescent Medicine; vol 9.
10. Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92:573-585.
11. de Lecea L, Kilduff TS, Peyron C, et al. The hypocretions: hypothalamus-specific peptides with neuroexcitatiry activity. Proc Natl Acad Sci U S A. 1998;95:322-327.
12. Lin L, Faraco J, Li R, et al. The sleep disorder canine narcolepsy is caused by a mutation in Hypocretin (Orexin) receptor 2 gene. Cell. 1999;98:365-376.
13. Shelton JK, Kosaka N, Perrino C et al. Role of leptin in sleep consolidation and circadian rhythmicity. Sleep. 2004;27(suppl):A31.